Karyopharm Therapeutics is pioneering the science of nuclear export inhibition to develop differentiated therapies for cancer patients. The company has an established commercial foundation in multiple myeloma and is advancing selinexor across hematologic and solid tumors, with a collaborative, fast-moving environment where individual contributions are valued.
Benefits Overview
1 of 1 jobs
401(k)
(1)
Dental
(1)
Equity
(1)
Medical
(1)
Vision
(1)